| Version |
1.0 |
| Creation Date |
2009-07-21 20:27:33 |
| Update Date |
2010-05-18 21:00:36 |
| Accession Number |
T3D2877 |
| Name |
Scopolamine |
| Compound Type |
- Adjuvant
- Adjuvant, Anesthesia
- Antimuscarinic
- Antispasmodic
- Cholinergic Antagonist
- Drug
- Muscarinic Antagonist
- Mydriatic
|
| Description |
Scopolamine is an alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. [PubChem] |
| Synonyms |
- (+)-hyoscine
- (+)-scopolamine
- (-)-hyoscine
- (-)-hyoscine hydrobromide
- (-)-scopolamine bromide
- (-)-scopolamine hydrobromide
- 6,7-Epoxytropine Tropate
- 6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropate
- 9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate
- Atrochin
- Atroquin
- Beldavrin
- Buscopan
- Buscopan Inj
- Buscopan Tab
- Epoxytropine tropate
- Euscopol
- Hydroscine hydrobromide
- Hyosceine
- Hyoscine
- Hyoscine bromide
- Hyoscine butylbromide injection sandoz standard
- Hyoscine hydrobromide
- Hyoscyine hydrobromide
- Hyosol
- Hysco
- Isopto hyoscine
- Isoscopil
- Kwells
- L-hyoscine hydrobromide
- L-scopolamine
- L-scopolamine-hydrobromide
- Methscopolamine bromide
- Oscine
- Pamine
- S-(-)-tropate
- SCOP
- SEE
- Scopamin
- Scopine tropate
- Scopoderm-TTS
- Scopolamine (hyoscine)
- Scopolamine bromide
- Scopolamine hydrobromide
- Scopolaminium bromide
- Scopolammonium bromide
- Skopolamin
- Tranaxine
- Transcop
- Transderm scop
- Transderm-scop
- Transderm-v
|
| Chemical IUPAC Name |
9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl 3-hydroxy-2-phenylpropanoate |
| Chemical Formula |
C17H21NO4 |
| Chemical Structure |
 |
| CAS Registry Number |
6533-68-2 |
| InChI Identifier |
InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3 |
| InChI Key |
InChIKey=STECJAGHUSJQJN-UHFFFAOYSA-N |
| PubChem Compound ID |
5184  |
| KEGG ID |
C01851  |
| UniProt ID |
Not Available |
| OMIM ID |
Not Available |
| ChEBI ID |
16794  |
| BioCyc ID |
SCOPOLAMINE  |
| SuperToxic ID |
Not Available |
| CTD ID |
Not Available |
| Stitch ID |
Scopolamine  |
| DrugBank ID |
DB00747  |
| PDB ID |
Not Available |
| ACToR ID |
Not Available |
| Wikipedia Link |
http://en.wikipedia.org/wiki/Scopolamine  |
| Monoisotopic Mass |
303.147058 |
| MOL File |
Show |
| PDB File |
Show |
| SDF File |
Show |
| SMILES |
CN1C2CC(CC1C1OC21)OC(=O)C(CO)C1=CC=CC=C1 |
| Appearance |
Not Available |
| Melting Point |
59 oC |
| Solubility |
Not Available |
| Predicted LogP |
0.895 |
| Route of Exposure |
Parental (intravenous, intramuscular, and transdermal); oral |
| Mechanism of Action |
Scopolamine acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center). |
| Metabolism |
Not Available |
| Toxicity Values |
Not Available |
| Lethal Dose |
Not Available |
| Carcinogenicity (IARC Classification) |
Not Available |
| Uses/Sources |
Not Available |
| Minimum Risk Level |
Not Available |
| Health Effects |
Not Available |
| Symptoms |
Not Available |
| Treatment |
Not Available |
| General References |
|
| Targets |
- Muscarinic acetylcholine receptor M1
|
|
Target 1
[top]
|
| Target 1 ID |
638 |
| Target 1 Name |
Muscarinic acetylcholine receptor M1 |
| Target 1 Mechanism of Action |
Scopolamine acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center). |
| Target 1 Description |
The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover |
| Target 1 Synonyms |
Not Available |
| Target 1 Gene Name |
CHRM1 |
| Target 1 Protein Sequence |
>Muscarinic acetylcholine receptor M1
MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVN
NYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLIS
FDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYI
QFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSS
SERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEV
VIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKE
KKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYAL
CNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC
|
| Target 1 Number of Residues |
460 |
| Target 1 Molecular Weight |
51420.4 |
| Target 1 Theoretical pI |
9.67 |
| Target 1 GO Classification |
|
Function
|
amine receptor activity
muscarinic acetylcholine receptor activity
signal transducer activity
receptor activity
transmembrane receptor activity
G-protein coupled receptor activity
rhodopsin-like receptor activity |
|
Process
|
cellular process
cell communication
signal transduction
cell surface receptor linked signal transduction
G-protein coupled receptor protein signaling pathway |
|
Component
|
cell
membrane
intrinsic to membrane
integral to membrane |
|
| Target 1 General Function |
Involved in muscarinic acetylcholine receptor activity |
| Target 1 Pathways |
Not Available |
| Target 1 Reactions |
Not Available |
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
- 25-47
- 62-82
- 100-121
- 142-164
- 187-209
- 367-387
- 402-421
|
| Target 1 Essentiality |
Non Essential |
| Target 1 Domain Function |
PF00001:7tm_1 |
| Target 1 GenBank ID Protein |
Not Available |
| Target 1 UniProtKB ID |
P11229  |
| Target 1 Cellular Location |
Cell membrane |
| Target 1 Gene Sequence |
Not Available |
| Target 1 GenBank Gene ID |
Not Available |
| Target 1 GeneCard ID |
CHRM1  |
| Target 1 GenAtlas ID |
CHRM1  |
| Target 1 HGNC ID |
HGNC:1950  |
| Target 1 Chromosome Location |
Chromosome:11 |
| Target 1 Locus |
11q13 |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 Toxin References |
- U322 - Murasaki O, Kaibara M, Nagase Y, Mitarai S, Doi Y, Sumikawa K, Taniyama K: Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction. J Pharmacol Exp Ther. 2003 Dec;307(3):995-1000. Epub 2003 Oct 8. [PubMed
]
|
| Target 1 General References |
3697105; 2336407; 3443095; 15489334; 1445347; 15086532 |